MLMSX
Price
$23.91
Change
+$0.11 (+0.46%)
Updated
Sep 8 closing price
Net Assets
48.16M
RPEBX
Price
$69.98
Change
+$0.65 (+0.94%)
Updated
Sep 8 closing price
Net Assets
159.21B
Interact to see
Advertisement

MLMSX vs RPEBX

Header iconMLMSX vs RPEBX Comparison
Open Charts MLMSX vs RPEBXBanner chart's image
Morgan Stanley Instl Global Core R6
Price$23.91
Change+$0.11 (+0.46%)
VolumeN/A
Net Assets48.16M
American Funds New Perspective R2E
Price$69.98
Change+$0.65 (+0.94%)
VolumeN/A
Net Assets159.21B
MLMSX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MLMSX vs. RPEBX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLMSX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 159B vs. MLMSX (48.2M). MLMSX pays higher dividends than RPEBX: MLMSX (0.19) vs RPEBX (0.12). MLMSX was incepted earlier than RPEBX: MLMSX (9 years) vs RPEBX (11 years). MLMSX (20.37) is less costly to investors than RPEBX (1.21). MLMSX is a more actively managed with annual turnover of: 39.00 vs. RPEBX (24.00). RPEBX has a lower initial minimum investment than MLMSX: RPEBX (250) vs MLMSX (5000000). MLMSX annual gain was more profitable for investors over the last year : 21.62 vs. RPEBX (16.51). MLMSX return over 5 years is better than : 70.60 vs. RPEBX (33.72).
MLMSXRPEBXMLMSX / RPEBX
Total Expense Ratio0.951.2179%
Annual Report Gross Expense Ratio20.371.211,683%
Fund Existence9 years11 years-
Gain YTD13.38715.38887%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets48.2M159B0%
Annual Yield % from dividends0.190.12158%
Returns for 1 year21.6216.51131%
Returns for 3 years61.6840.50152%
Returns for 5 years70.6033.72209%
Returns for 10 yearsN/A91.03-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNTX0.840.02
+1.89%
Context Therapeutics
SCM15.020.22
+1.49%
STELLUS CAPITAL INVESTMENT Corp
AIZ211.750.58
+0.27%
Assurant
KLG22.980.01
+0.04%
WK Kellogg Co
GTBP0.86-0.08
-8.68%
GT Biopharma